138 related articles for article (PubMed ID: 37882324)
1. Survival outcomes for lung neuroendocrine tumors in California differ by sociodemographic factors.
Mulvey CK; Paciorek A; Moon F; Steiding P; Shih B; Gubens MA; Zhang L; Bergsland EK; Cheng I
Endocr Relat Cancer; 2024 Jan; 31(1):. PubMed ID: 37882324
[TBL] [Abstract][Full Text] [Related]
2. Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States.
Costa LJ; Brill IK; Brown EE
Cancer; 2016 Oct; 122(20):3183-3190. PubMed ID: 27548407
[TBL] [Abstract][Full Text] [Related]
3. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
[TBL] [Abstract][Full Text] [Related]
4. Differential Outcomes Among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups.
Taylor DB; Osazuwa-Peters OL; Okafor SI; Boakye EA; Kuziez D; Perera C; Simpson MC; Barnes JM; Bulbul MG; Cannon TY; Watts TL; Megwalu UC; Varvares MA; Osazuwa-Peters N
JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):119-127. PubMed ID: 34940784
[TBL] [Abstract][Full Text] [Related]
5. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
6. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
[TBL] [Abstract][Full Text] [Related]
8. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
[TBL] [Abstract][Full Text] [Related]
9. Geographic and demographic features of neuroendocrine tumors in the United States of America: A population-based study.
Gosain R; Ball S; Rana N; Groman A; Gage-Bouchard E; Dasari A; Mukherjee S
Cancer; 2020 Feb; 126(4):792-799. PubMed ID: 31714595
[TBL] [Abstract][Full Text] [Related]
10. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): Prevalence, clinicopathological characteristics and survival outcome in a cohort of 311 patients with well-differentiated lung neuroendocrine tumours.
Hayes AR; Luong TV; Banks J; Shah H; Watkins J; Lim E; Patel A; Grossman AB; Navalkissoor S; Krell D; Caplin ME
J Neuroendocrinol; 2022 Oct; 34(10):e13184. PubMed ID: 36121922
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
Punekar SR; Kaakour D; Masri-Lavine L; Hajdu C; Newman E; Becker DJ
Am J Clin Oncol; 2020 Dec; 43(12):846-849. PubMed ID: 32910023
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old.
Hsu CD; Wang X; Habif DV; Ma CX; Johnson KJ
Cancer; 2017 Aug; 123(16):3125-3131. PubMed ID: 28440864
[TBL] [Abstract][Full Text] [Related]
13. Effect of insurance type on perioperative outcomes after robotic-assisted pulmonary lobectomy for lung cancer.
Deol PS; Sipko J; Kumar A; Tsalatsanis A; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
Surgery; 2019 Aug; 166(2):211-217. PubMed ID: 31202473
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of thermal ablation for the treatment of pulmonary carcinoid tumor: a propensity-matched analysis.
Yang H; Li M; Liu T; Luo L
Int J Hyperthermia; 2023; 40(1):2225817. PubMed ID: 37364893
[TBL] [Abstract][Full Text] [Related]
15. Sociodemographic Survival Disparities for Lung Cancer in the United States, 2000-2016.
Brouwer AF; Engle JM; Jeon J; Meza R
J Natl Cancer Inst; 2022 Nov; 114(11):1492-1500. PubMed ID: 35866998
[TBL] [Abstract][Full Text] [Related]
16. Sex-based differences in the outcomes of patients with lung carcinoids.
Abdel-Rahman O; Ghosh S; Fazio N
J Comp Eff Res; 2022 May; 11(7):523-531. PubMed ID: 35388711
[No Abstract] [Full Text] [Related]
17. Hispanics/Latinos in the Bronx Have Improved Survival in Non-Small Cell Lung Cancer Compared with Non-Hispanic Whites.
Klugman M; Xue X; Ginsberg M; Cheng H; Rohan T; Hosgood HD
J Racial Ethn Health Disparities; 2020 Apr; 7(2):316-326. PubMed ID: 31713221
[TBL] [Abstract][Full Text] [Related]
18. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
19. Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.
Sung JM; Martin JW; Jefferson FA; Sidhom DA; Piranviseh K; Huang M; Nguyen N; Chang J; Ziogas A; Anton-Culver H; Youssef RF
Clin Genitourin Cancer; 2019 Oct; 17(5):e995-e1002. PubMed ID: 31239240
[TBL] [Abstract][Full Text] [Related]
20. Second primary cancers and survival among neuroendocrine tumor patients.
Bateni SB; Coburn NG; Law C; Singh S; Myrehaug S; Assal A; Hallet J
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37184947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
